Abstract:Background: Histopathological assessment of transplant biopsies is currently the standard method to diagnose allograft rejection and can help guide patient management, but it is one of the most challenging areas of pathology, requiring considerable expertise, time, and effort. We aimed to analyse the utility of deep learning to preclassify histology of kidney allograft biopsies into three main broad categories (ie, normal, rejection, and other diseases) as a potential biopsy triage system focusing on transplant rejection. Methods: We performed a retrospective, multicentre, proof-of-concept study using 5844 digital whole slide images of kidney allograft biopsies from 1948 patients. Kidney allograft biopsy samples were identified by a database search in the Departments of Pathology of the Amsterdam UMC, Amsterdam, Netherlands (1130 patients) and the University Medical Center Utrecht, Utrecht, Netherlands (717 patients). 101 consecutive kidney transplant biopsies were identified in the archive of the Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany. Convolutional neural networks (CNNs) were trained to classify allograft biopsies as normal, rejection, or other diseases. Three times cross-validation (1847 patients) and deployment on an external real-world cohort (101 patients) were used for validation. Area under the receiver operating characteristic curve (AUROC) was used as the main performance metric (the primary endpoint to assess CNN performance). Findings: Serial CNNs, first classifying kidney allograft biopsies as normal (AUROC 0·87 [ten times bootstrapped CI 0·85-0·88]) and disease (0·87 [0·86-0·88]), followed by a second CNN classifying biopsies classified as disease into rejection (0·75 [0·73-0·76]) and other diseases (0·75 [0·72-0·77]), showed similar AUROC in cross-validation and deployment on independent real-world data (first CNN normal AUROC 0·83 [0·80-0·85], disease 0·83 [0·73-0·91]; second CNN rejection 0·61 [0·51-0·70], other diseases 0·61 [0·50-0·74]). A single CNN classifying biopsies as normal, rejection, or other diseases showed similar performance in cross-validation (normal AUROC 0·80 [0·73-0·84], rejection 0·76 [0·66-0·80], other diseases 0·50 [0·36-0·57]) and generalised well for normal and rejection classes in the real-world data. Visualisation techniques highlighted rejection-relevant areas of biopsies in the tubulointerstitium. Interpretation: This study showed that deep learning-based classification of transplant biopsies could support pathological diagnostics of kidney allograft rejection. Funding: European Research Council; German Research Foundation; German Federal Ministries of Education and Research, Health, and Economic Affairs and Energy; Dutch Kidney Foundation; Human(e) AI Research Priority Area of the University of Amsterdam; and Max-Eder Programme of German Cancer Aid.

Deep learning predicts the differentiation of kidney organoids derived from human induced pluripotent stem cells

Convolutional Neural Networks Can Predict Retinal Differentiation in Retinal Organoids

Using Deep Learning to Predict Neural Stem Cell Differentiation in Regenerative Medicine

Morphology-Based Deep Learning Approach for Predicting Osteogenic Differentiation

Prediction of Stem Cell State Using Cell Image‐Based Deep Learning

Recognizing the Differentiation Degree of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cells Using Machine Learning and Deep Learning-Based Approaches

Deep learning-enabled classification of kidney allograft rejection on whole slide histopathologic images

Noninvasive Assessment of hiPSC Differentiation toward Cardiomyocytes Using Pretrained Convolutional Neural Networks and the Channel Pruning Algorithm

Classification of C2C12 cells at differentiation by convolutional neural network of deep learning using phase contrast images

Automated Classification of Papillary Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma Based on a Small Computed Tomography Imaging Dataset Using Deep Learning

Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learning

Deep Learning Powered Identification of Differentiated Early Mesoderm Cells from Pluripotent Stem Cells

Use of Deep Learning to Predict Acute Kidney Injury After Intravenous Contrast Media Administration: Prediction Model Development Study

Deep Learning Identifies Intelligible Predictors of Poor Prognosis in Chronic Kidney Disease

A deep learning model for drug screening and evaluation in bladder cancer organoids

A Comprehensive Study of Deep Learning Methods for Kidney Tumor, Cyst, and Stone Diagnostics and Detection Using CT Images

Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis

Smartphone-based machine learning model for real-time assessment of medical kidney biopsy

Single Cell Sequencing and Kidney Organoids Generated from Pluripotent Stem Cells

DevKidCC allows for robust classification and direct comparisons of kidney organoid datasets

Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study